NEUCHATEL, SWITZERLAND--(Marketwired - Oct 10, 2014) - Masimo (NASDAQ: MASI), maker of breakthrough Masimo SET ® Measure-through Motion and Low Perfusion™ Pulse Oximetry, today announced the CE Mark ...
The investigators enrolled 33 patients in this study. Eight of these resumed spontaneous ventilation during the study period, leaving 25 apneic patients to evaluate, with an average age of 7.6 years.
Masimo Corporation MASI recently announced that Ranken Jordan Pediatric Bridge Hospital has upgraded its patient monitors to Radical-7, which features Masimo SET pulse oximetry. The Radical-7 is ...
Masimo SET ® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, 1 improve CCHD screening in newborns, 3 and, when used for continuous monitoring with Masimo ...
For best results when printing this announcement, please click on the linkbelow: http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results